on 30 May 2014
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2014 to consider and approve the Audited financial results for the quarter/year ended 31 March 2014, and Recommend dividend, if any, for the year ended 31 March 2014.Powered by Capital Market - Live News
